Cooler Heads Showcases Patient Outcomes for FDA-Cleared Scalp Cooling Device

According to a recent LinkedIn post from Cooler Heads, the company is emphasizing patient experiences with its Amma scalp cooling system during chemotherapy. The post highlights before-and-after visual results and suggests that preserving hair can play a role in how patients feel throughout cancer treatment.

The LinkedIn content also notes that Amma is an FDA-cleared scalp cooling device intended to help minimize hair loss in adult solid-tumor patients. For investors, this emphasis on real-world outcomes and quality-of-life benefits may support market adoption, strengthen the brand in the oncology-support space, and potentially enhance Cooler Heads’ competitive positioning in the niche of supportive cancer care technologies.